Patel Brijesh, Carson Philip, Shah Mahek, Garg Lohit, Agarwal Manyoo, Agrawal Sahil, Arora Shilpkumar, Steigerwalt Susan, Bavry Anthony, Dusaj Raman, Patel Nainesh, Feldman Bruce
Divison of Cardiology, Lehigh Valley Hospital, Allentown, Pennsylvania.
Divison of Internal Medicine, University of Tennessee Health Science Center, Memphis.
Clin Cardiol. 2017 Dec;40(12):1303-1308. doi: 10.1002/clc.22828. Epub 2017 Dec 20.
Chronic kidney disease (CKD) is a well-known risk factor for coronary artery disease and is associated with poor outcomes following an acute coronary syndrome (NSTE-ACS). The optimal timing of an invasive strategy in patients with CKD and NSTE-ACS is unclear.
Timing of PCI in CKD patients will not affect the risk of mortality or incidence of dialysis.
We queried the National Inpatient Sample database (NIS) to identify cases with NSTEMI and CKD. Patients who underwent percutaneous coronary intervention (PCI) day 0 or 1 vs day 2 or 3 after admission were categorized as early vs delayed PCI, respectively. The primary outcomes of the study were in-hospital mortality and acute kidney injury requiring hemodialysis (AKI-D). The secondary outcomes were length of stay and hospital charges. Baseline characteristics were balanced using propensity score matching (PSM).
After PSM, 3708 cases from the delayed PCI group were matched with 3708 cases from the early PCI group. The standardized mean differences between the 2 groups were substantially reduced after PSM. All other recorded variables were balanced between the 2 groups. In the early and delayed PCI groups, the incidence of AKI-D (2.5% vs 2.3%; P = 0.54) and in-hospital mortality (1.9% vs 1.4%; P = 0.12) was similar. Hospital charges and length of stay were higher in the delayed PCI group.
The incidence of AKI-D and in-hospital mortality among patients with CKD and NSTE-ACS were not significantly affected by the timing of PCI. However, delayed PCI added significant cost and length of stay. A prospective randomized study is required to validate this concept.
慢性肾脏病(CKD)是冠状动脉疾病的一个众所周知的危险因素,并且与急性冠状动脉综合征(非ST段抬高型急性冠状动脉综合征,NSTE-ACS)后的不良结局相关。CKD合并NSTE-ACS患者进行侵入性策略的最佳时机尚不清楚。
CKD患者进行经皮冠状动脉介入治疗(PCI)的时机不会影响死亡率风险或透析发生率。
我们查询了国家住院患者样本数据库(NIS)以识别非ST段抬高型心肌梗死(NSTEMI)和CKD病例。入院后第0天或第1天接受PCI的患者与入院后第2天或第3天接受PCI的患者分别被归类为早期PCI组和延迟PCI组。该研究的主要结局是住院死亡率和需要血液透析的急性肾损伤(AKI-D)。次要结局是住院时间和住院费用。使用倾向评分匹配(PSM)使基线特征达到平衡。
经过PSM后,延迟PCI组的3708例病例与早期PCI组的3708例病例进行了匹配。PSM后两组之间的标准化均值差异大幅降低。两组之间所有其他记录的变量均达到平衡。在早期和延迟PCI组中,AKI-D的发生率(2.5%对2.3%;P = 0.54)和住院死亡率(1.9%对1.4%;P = 0.12)相似。延迟PCI组的住院费用和住院时间更高。
CKD合并NSTE-ACS患者中AKI-D的发生率和住院死亡率不受PCI时机的显著影响。然而,延迟PCI增加了显著的费用和住院时间。需要进行前瞻性随机研究来验证这一概念。